Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03077087 · ClinicalTrials.gov registry record · NA
Single-Stage Integra Reconstruction in Burns
A NA study, sponsored by HealthPartners Institute.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03077087: Clinical Trial NA study, sponsored by HealthPartners Institute.
NCT03077087 is a NA study that was terminated before completion, run by HealthPartners Institute. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03077087, a NA study, was terminated before completion, sponsored by HealthPartners Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a prospective, descriptive, pilot case series involving patients with significant burns who are candidates for reconstruction with Integra®. Subjects would have a small area of the wound would, at the time of excision, have the smallest sheet of thin Integra® (125 cm2) placed and be immediately autografted with a 3:1 meshed split-thickness skin graft. Of note, 125 cm2 represents approximately 0.7% of an average sized patient's total body surface area, so for even the smallest burns in our proposed trial, this area would represent a small portion of the patient's area of injury. The remaining injury areas would be covered with standard-thickness Integra® only.
Primary Outcome
95% healing determined as charted in Standard of Care follow up visits
Interventions
- DEVICE thin Integra® (125 cm2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-04-10 |
| Est. Completion | 2019-07-24 |
| Phase | NA |
Why NCT03077087 stopped before completion
NCT03077087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which thin Integra® (125 cm2) is the first listed.
NCT03077087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03077087 about?
NCT03077087 is a clinical study titled "Single-Stage Integra Reconstruction in Burns". This is a prospective, descriptive, pilot case series involving patients with significant burns who are candidates for reconstruction with Integra®. Subjects would have a small area of the wound would, at the time of excision, have the smallest sheet of thin Integra® (125 cm2) placed and be immediat...
What is the current status of trial NCT03077087?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-04-10. Estimated completion is 2019-07-24.
What interventions are being tested in trial NCT03077087?
The interventions under investigation include: thin Integra® (125 cm2) (DEVICE).
Who is sponsoring clinical trial NCT03077087?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03077087's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI